tradingkey.logo
tradingkey.logo
Search

Tempus AI Inc

TEM
Add to Watchlist
51.940USD
+3.330+6.85%
Close 06/24, 16:00ETQuotes delayed by 15 min
9.33BMarket Cap
LossP/E TTM

More Details of Tempus AI Inc Company

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

Tempus AI Inc Info

Ticker SymbolTEM
Company nameTempus AI Inc
IPO dateMay 30, 2025
CEOLefkofsky (Eric P)
Number of employees2400
Security typeOrdinary Share
Fiscal year-endMay 30
Address600 West Chicago Avenue
CityCHICAGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code60654
Phone18335144187
Websitehttps://investors.tempus.com/
Ticker SymbolTEM
IPO dateMay 30, 2025
CEOLefkofsky (Eric P)

Company Executives of Tempus AI Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
693.91K
-23.89%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
112.64K
+5.25%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
30.28K
+4.28%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
26.67K
+22.17%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
26.05K
-3.27%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
16.68K
-1.50%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
14.80K
+91.55%
Mr. Eric P. Lefkofsky, J.D.
Mr. Eric P. Lefkofsky, J.D.
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Erik J. Phelps, J.D.
Mr. Erik J. Phelps, J.D.
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary
--
--
Dr. Jennifer A. Doudna, Ph.D.
Dr. Jennifer A. Doudna, Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
693.91K
-23.89%
Mr. Peter J. Barris
Mr. Peter J. Barris
Independent Director
Independent Director
112.64K
+5.25%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
30.28K
+4.28%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
26.67K
+22.17%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
26.05K
-3.27%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
16.68K
-1.50%

FAQs

Who are the top five shareholders of Tempus AI Inc?

The top five shareholders of Tempus AI Inc are: Mr. Ryan Fukushima

How many institutions hold shares of Tempus AI Inc (TEM)?

As of 2026Q1, 847 institutions hold shares of Tempus AI Inc, with a combined market value of approximately 109.28M, accounting for 62.62% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 6294807.00.
KeyAI